- Home
- MVST vs AMRN Comparison
MVST vs AMRN Comparison
Compare MVST & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVST
- AMRN
- Stock Information
- Founded
- MVST 2006
- AMRN 1989
- Country
- MVST United States
- AMRN Ireland
- Employees
- MVST N/A
- AMRN N/A
- Industry
- MVST Industrial Machinery/Components
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- MVST Miscellaneous
- AMRN Health Care
- Exchange
- MVST Nasdaq
- AMRN Nasdaq
- Market Cap
- MVST 182.8M
- AMRN 189.2M
- IPO Year
- MVST N/A
- AMRN 1993
- Fundamental
- Price
- MVST $2.18
- AMRN $0.63
- Analyst Decision
- MVST Buy
- AMRN Buy
- Analyst Count
- MVST 3
- AMRN 1
- Target Price
- MVST $3.33
- AMRN N/A
- AVG Volume (30 Days)
- MVST 17.4M
- AMRN 1.6M
- Earning Date
- MVST 11-12-2024
- AMRN 02-27-2025
- Dividend Yield
- MVST N/A
- AMRN N/A
- EPS Growth
- MVST N/A
- AMRN N/A
- EPS
- MVST N/A
- AMRN N/A
- Revenue
- MVST $370,989,000.00
- AMRN $241,021,000.00
- Revenue This Year
- MVST $19.19
- AMRN N/A
- Revenue Next Year
- MVST $29.35
- AMRN N/A
- P/E Ratio
- MVST N/A
- AMRN N/A
- Revenue Growth
- MVST 39.03
- AMRN N/A
- 52 Week Low
- MVST $0.15
- AMRN $0.43
- 52 Week High
- MVST $2.87
- AMRN $1.37
- Technical
- Relative Strength Index (RSI)
- MVST 56.49
- AMRN 66.95
- Support Level
- MVST $1.92
- AMRN $0.43
- Resistance Level
- MVST $2.30
- AMRN $0.49
- Average True Range (ATR)
- MVST 0.28
- AMRN 0.04
- MACD
- MVST -0.06
- AMRN 0.01
- Stochastic Oscillator
- MVST 34.29
- AMRN 73.29
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extend from core battery chemistry to battery packs.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.